T. Guilbert, A. Deschildre, D. Jackson, P. Bégin, R. Zeiger, S. Szefler, A. Altincatal, R. Gall, J. Jacob-Nara, P. Rowe, Y. Deniz, M. Djandji
{"title":"Dupilumab在伴有或不伴有持续特应性共病的未控制的中重度哮喘患儿中的疗效:LIBERTY Asthma VOYAGE","authors":"T. Guilbert, A. Deschildre, D. Jackson, P. Bégin, R. Zeiger, S. Szefler, A. Altincatal, R. Gall, J. Jacob-Nara, P. Rowe, Y. Deniz, M. Djandji","doi":"10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a2364","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":166658,"journal":{"name":"B15. NOVEL BIOMARKERS AND USES OF THERAPEUTICS IN ASTHMA","volume":"47 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Efficacy of Dupilumab in Pediatric Patients with Uncontrolled, Moderate-to-Severe Asthma With and Without Ongoing Atopic Comorbid Disease: LIBERTY ASTHMA VOYAGE\",\"authors\":\"T. Guilbert, A. Deschildre, D. Jackson, P. Bégin, R. Zeiger, S. Szefler, A. Altincatal, R. Gall, J. Jacob-Nara, P. Rowe, Y. Deniz, M. Djandji\",\"doi\":\"10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a2364\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":166658,\"journal\":{\"name\":\"B15. NOVEL BIOMARKERS AND USES OF THERAPEUTICS IN ASTHMA\",\"volume\":\"47 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"B15. NOVEL BIOMARKERS AND USES OF THERAPEUTICS IN ASTHMA\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a2364\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"B15. NOVEL BIOMARKERS AND USES OF THERAPEUTICS IN ASTHMA","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a2364","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Efficacy of Dupilumab in Pediatric Patients with Uncontrolled, Moderate-to-Severe Asthma With and Without Ongoing Atopic Comorbid Disease: LIBERTY ASTHMA VOYAGE